CERTIS ONCOLOGY PARTNERS WITH REVEAL BIOSCIENCES TO OFFER ADVANCED PRE-CLINICAL ONCOLOGY SERVICES SAN DIEGO, AUGUST 13, 2018. Certis Oncology Solutions and Reveal Biosciences today announced a strategic partnership in which the two companies will collaborate to provide an innovative, next-generation suite of pre-clinical oncology services. Under the agreement, Reveal will leverage its Artificial Intelligence (AI)-based pathology tools to generate advanced
You can now access the Certis Oncology profile and request our orthotopic PDX pre-clinical services at https://www.scientist.com/researchers/. Our research team is looking forward to working with you!
CERTIS ONCOLOGY ANNOUNCES CLIA CERTIFICATION FOR HIGH-COMPLEXITY TESTING The Company has designed Laboratory Developed Tests for its innovative orthotopic PDX mouse modeling techniques to determine the best treatment options for cancer patients. SAN DIEGO, JULY 16, 2018. Certis Oncology Solutions, Inc., a new precision medicine company focused on individualized patient care, today announced that it has received its CLIA Certificate
Thank you to La Jolla Playhouse for a fantastic Innovation Night! Peter Ellman (CEO) and Jonathan Nakashima, PhD (Director of Operations) and the rest of our team enjoyed meeting everyone!
Dr. Arun Singh, a Stand up to Cancer researcher and UCLA doctor, joins the panel to share how people can get involved. “Go to getscreenednow.org and take a quick survey to find out which cancer screening tests may be right for you. Take the pledge and make an appointment to speak with your physician about cancer screening recommendations which can
Fritz Eilber, MD and Arun Singh, MD chat with UCLA oncology patient Rachel Young Huff about precision medicine opportunities for patients with in vivo mouse models.
Fritz Eilber, MD and Arun Singh, MD chat with UCLA oncology patient Rachel Young Huff about the research opportunity for PDOX mouse models.
Fritz Eilber, MD and Arun Singh, MD chat with UCLA oncology patient Rachel Young Huff about her PDOX mouse models.
Last week we lost a beloved member of the Certis Oncology family. As she participated in our research,Rachel became our close friend. She inspired us with her uncommon bravery, her ironic sense of humor, her vitality and her brilliant life energy. She leaves behind her husband Forrest, two beautiful children, a large extended family and a loving community. When we remember Rachel, we’ll